Skip to main content
Erschienen in: Journal of General Internal Medicine 7/2009

01.07.2009 | Original Article

Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?

verfasst von: Melissa A. Fischer, MD, MEd, Mary Ellen Keough, MPH, Joann L. Baril, BS, Laura Saccoccio, BS, Kathleen M. Mazor, EdD, Elissa Ladd, PhD, RN, FNP, Ann Von Worley, RN, BS, CCRP, Jerry H. Gurwitz, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

ABSTRACT

CONTEXT

Research suggests that pharmaceutical marketing influences prescribing and may cause cognitive dissonance for prescribers. This work has primarily been with physicians and physician–trainees. Questions remain regarding why prescribers continue to meet with pharmaceutical representatives (PRs).

OBJECTIVE

To describe the reasons that prescribers from various health professions continue to interact with PRs despite growing evidence of the influence of these interactions.

DESIGN, SETTING, AND PARTICIPANTS

Multi-disciplinary focus groups with 61 participants held in practice settings and at society meetings.

RESULTS

Most prescribers participating in our focus groups believe that overall PR interactions are beneficial to patient care and practice health. They either trust the information from PRs or feel that they are equipped to evaluate it independently. Despite acknowledgement of study findings to the contrary, prescribers state that they are able to effectively manage PR interactions such that their own prescribing is not adversely impacted. Prescribers describe few specific strategies or policies for these interactions, and report that policies are not consistently implemented with all members of a clinic or institution. Some prescribers perceive an inherent contradiction between academic centers and national societies receiving money from pharmaceutical companies, and then recommending restriction at the level of the individual prescriber. Prescribers with different training backgrounds present a few novel reasons for these meetings.

CONCLUSIONS

Despite evidence that PR detailing influences prescribing, providers from several health professions continue to believe that PR interactions improve patient care, and that they can adequately evaluate and filter information presented to them by PRs. Focus group comments suggest that cultural change is necessary to break the norms that exist in many settings. Applying policies consistently, considering non-physician members of the healthcare team, working with trainees, restructuring the current primary care model and offering convenient, individualized, non-biased educational options may aid success.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med. 1988;26(12):1183–9.PubMedCrossRef Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med. 1988;26(12):1183–9.PubMedCrossRef
2.
Zurück zum Zitat Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73(1):4–8.PubMedCrossRef Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73(1):4–8.PubMedCrossRef
3.
Zurück zum Zitat Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373–80.PubMedCrossRef Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373–80.PubMedCrossRef
4.
Zurück zum Zitat Banks JW 3rd, Mainous AG 3rd. Attitudes of medical school faculty towards gifts from the pharmaceutical industry. Acad Med. 1992;67(9):610–2.PubMedCrossRef Banks JW 3rd, Mainous AG 3rd. Attitudes of medical school faculty towards gifts from the pharmaceutical industry. Acad Med. 1992;67(9):610–2.PubMedCrossRef
5.
Zurück zum Zitat Steinman M, Shlipak M, McPhee S. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110(7):551–7.PubMedCrossRef Steinman M, Shlipak M, McPhee S. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110(7):551–7.PubMedCrossRef
6.
Zurück zum Zitat Brennan T, Rothman D, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;294(4):429–33.CrossRef Brennan T, Rothman D, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;294(4):429–33.CrossRef
7.
Zurück zum Zitat Minnigan H, Chisholm CD. Conflict of interest in the physician interface with the biomedical industry. E Med Clin N Amer. 2006;4(3):671–85.CrossRef Minnigan H, Chisholm CD. Conflict of interest in the physician interface with the biomedical industry. E Med Clin N Amer. 2006;4(3):671–85.CrossRef
8.
Zurück zum Zitat Campo K, De Staebel O, Gijsbrechts E, van Waterschoot W. Physician’s decision process for drug prescription and the impact of pharmaceutical marketing mix instruments. Health Mark Quar. 2005;2(4):73–107. Campo K, De Staebel O, Gijsbrechts E, van Waterschoot W. Physician’s decision process for drug prescription and the impact of pharmaceutical marketing mix instruments. Health Mark Quar. 2005;2(4):73–107.
9.
Zurück zum Zitat Vainiomaki M, Helve O, Vuorenkoski L. A national survey on the effect of pharmaceutical promotion on medical students. Med Teach. 2004;6(7):630–4.CrossRef Vainiomaki M, Helve O, Vuorenkoski L. A national survey on the effect of pharmaceutical promotion on medical students. Med Teach. 2004;6(7):630–4.CrossRef
10.
Zurück zum Zitat Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118(8):881–4.PubMedCrossRef Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118(8):881–4.PubMedCrossRef
11.
Zurück zum Zitat Crigger NJ. Pharmaceutical promotions and conflict of interest in nurse practitioner’s decision: making the undiscovered country. J Am Acad NP. 2005;17(6):207–12.CrossRef Crigger NJ. Pharmaceutical promotions and conflict of interest in nurse practitioner’s decision: making the undiscovered country. J Am Acad NP. 2005;17(6):207–12.CrossRef
12.
Zurück zum Zitat Nissen S, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457–71.PubMedCrossRef Nissen S, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457–71.PubMedCrossRef
13.
Zurück zum Zitat Rosen C. The rosiglitazone story – lessons from an FDA advisory committee meeting. N Engl J Med. 2007;357(9):844–6.PubMedCrossRef Rosen C. The rosiglitazone story – lessons from an FDA advisory committee meeting. N Engl J Med. 2007;357(9):844–6.PubMedCrossRef
14.
Zurück zum Zitat Abramson J. Overdo$ed America: The Broken Promise of American Medicine. New York: Harper Collins; 2004. Abramson J. Overdo$ed America: The Broken Promise of American Medicine. New York: Harper Collins; 2004.
15.
Zurück zum Zitat Angell M. The Truth About the Drug Companies: How They Deceive Us and What To Do About It. New York: Random House, Inc.; 2004. Angell M. The Truth About the Drug Companies: How They Deceive Us and What To Do About It. New York: Random House, Inc.; 2004.
16.
Zurück zum Zitat Avorn J. Powerful medicines. The Benefits, Risks and Costs of Prescription Drugs. New York: Alfred a Knopf/Random House, Inc.; 2004. Avorn J. Powerful medicines. The Benefits, Risks and Costs of Prescription Drugs. New York: Alfred a Knopf/Random House, Inc.; 2004.
20.
Zurück zum Zitat Murphy S. Drug Sale Said Tied to Favors at Lahey. The Boston Globe. November 9, 2002. Page A1. Murphy S. Drug Sale Said Tied to Favors at Lahey. The Boston Globe. November 9, 2002. Page A1.
21.
Zurück zum Zitat Steinman MA, Bero LA, Chresn M, Landefeld CS. Narrative review. The promotion of gabapentin: an analysis of internal industry documents. Ann Int Med. 2006;145(4):284–93.PubMed Steinman MA, Bero LA, Chresn M, Landefeld CS. Narrative review. The promotion of gabapentin: an analysis of internal industry documents. Ann Int Med. 2006;145(4):284–93.PubMed
22.
Zurück zum Zitat Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742–50.PubMedCrossRef Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742–50.PubMedCrossRef
23.
Zurück zum Zitat Chimonas S, Brannan TA, Rothman DJ. Physicians and drug representatives: exploring the dynamics of the relationship. J Gen Intern Med. 2007;22(2):184–90.PubMedCrossRef Chimonas S, Brannan TA, Rothman DJ. Physicians and drug representatives: exploring the dynamics of the relationship. J Gen Intern Med. 2007;22(2):184–90.PubMedCrossRef
24.
Zurück zum Zitat Sierles FS, Brodkey AC, Cleary LM, et al. Medical students’ exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294(9):1034–42.PubMedCrossRef Sierles FS, Brodkey AC, Cleary LM, et al. Medical students’ exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294(9):1034–42.PubMedCrossRef
25.
Zurück zum Zitat McKinney WP, Schiedermayer DL, Luria N, et al. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264(13):1693–7.PubMedCrossRef McKinney WP, Schiedermayer DL, Luria N, et al. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264(13):1693–7.PubMedCrossRef
26.
Zurück zum Zitat Bellin M, Mccarthy S, Drevlow L, Pierach C. Medical student’ exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med. 2004;74(11):1041–5.CrossRef Bellin M, Mccarthy S, Drevlow L, Pierach C. Medical student’ exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med. 2004;74(11):1041–5.CrossRef
27.
Zurück zum Zitat Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003;163(18):2213–8.PubMedCrossRef Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003;163(18):2213–8.PubMedCrossRef
28.
Zurück zum Zitat Zipkin D, Steinman M. Interactions between PRs and doctors in training. A thematic review. J Gen Intern Med. 2005;20(8):777–86.PubMedCrossRef Zipkin D, Steinman M. Interactions between PRs and doctors in training. A thematic review. J Gen Intern Med. 2005;20(8):777–86.PubMedCrossRef
31.
Zurück zum Zitat Kuehn B. Pharmaceutical industry funding for residencies sparks controversy. JAMA. 2005;293:1572–80.PubMedCrossRef Kuehn B. Pharmaceutical industry funding for residencies sparks controversy. JAMA. 2005;293:1572–80.PubMedCrossRef
34.
Zurück zum Zitat American College of PhysiciansAmerican Society of Internal Medicine. Position Paper. Pharmacist scope of practice. Ann Intern Med. 2002;136:79–85. American College of PhysiciansAmerican Society of Internal Medicine. Position Paper. Pharmacist scope of practice. Ann Intern Med. 2002;136:79–85.
40.
Zurück zum Zitat Hagen B, Pijl-Zieber EM, Souveny K, Lacroix A. Let’s do lunch? The ethics of accepting gifts from the pharmaceutical industry. Can Nurse. 2008;104(4):30–5.PubMed Hagen B, Pijl-Zieber EM, Souveny K, Lacroix A. Let’s do lunch? The ethics of accepting gifts from the pharmaceutical industry. Can Nurse. 2008;104(4):30–5.PubMed
41.
Zurück zum Zitat Stokamer CL. Pharmaceutical gift giving: analysis of an ethical dilemma. J Nurs Admin. 2003;33(1):48–51.CrossRef Stokamer CL. Pharmaceutical gift giving: analysis of an ethical dilemma. J Nurs Admin. 2003;33(1):48–51.CrossRef
42.
Zurück zum Zitat Prosser H, Walley T. Understanding why GPs see pharmaceutical representatives: a qualitative interview study. Br J Gen Pract. 2003;53(489):305–11.PubMed Prosser H, Walley T. Understanding why GPs see pharmaceutical representatives: a qualitative interview study. Br J Gen Pract. 2003;53(489):305–11.PubMed
43.
Zurück zum Zitat Wofford J, Ohl C. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Ed. 2005;5(1):5.CrossRef Wofford J, Ohl C. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Ed. 2005;5(1):5.CrossRef
44.
Zurück zum Zitat Cialdini R. Influence: Science and Practice 4th ed. Needham Heights, MA: Allyn & Bacon; 2001. Cialdini R. Influence: Science and Practice 4th ed. Needham Heights, MA: Allyn & Bacon; 2001.
45.
Zurück zum Zitat Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med. 2004;9(11):1046–50.CrossRef Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med. 2004;9(11):1046–50.CrossRef
46.
Zurück zum Zitat Anastasio G, Little JM Jr. Pharmaceutical marketing: implications for medical residency training. Pharmacother. 1996;16(1):103–7. Anastasio G, Little JM Jr. Pharmaceutical marketing: implications for medical residency training. Pharmacother. 1996;16(1):103–7.
47.
Zurück zum Zitat Vinson DC, McCandless B, Hosokawa MC. Medical students’ attitudes toward pharmaceutical marketing: possibilities for change. Fam Med. 1993;25(1):31–3.PubMed Vinson DC, McCandless B, Hosokawa MC. Medical students’ attitudes toward pharmaceutical marketing: possibilities for change. Fam Med. 1993;25(1):31–3.PubMed
48.
Zurück zum Zitat Nelson CP, Bloom DA. Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications. J Urol. 2001;166(6):2317–20.PubMedCrossRef Nelson CP, Bloom DA. Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications. J Urol. 2001;166(6):2317–20.PubMedCrossRef
49.
Zurück zum Zitat Greene J. Pharmaceutical marketing research and the prescribing physician. Ann Int Med. 2007;146:742–8.PubMed Greene J. Pharmaceutical marketing research and the prescribing physician. Ann Int Med. 2007;146:742–8.PubMed
50.
Zurück zum Zitat Monaghan MS, Galt KA, Turner PD, et al. Student understanding of the relationship between the health professions and the pharmaceutical industry. TLM. 2003;15(1):14–20.CrossRef Monaghan MS, Galt KA, Turner PD, et al. Student understanding of the relationship between the health professions and the pharmaceutical industry. TLM. 2003;15(1):14–20.CrossRef
51.
Zurück zum Zitat Larson K, Levy J, Rome MG, Matte TD, Silver LD, Frieden TR. Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City. Pub Health Rep. 2006;121(3):228–34. Larson K, Levy J, Rome MG, Matte TD, Silver LD, Frieden TR. Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City. Pub Health Rep. 2006;121(3):228–34.
52.
Zurück zum Zitat Soumerai SB, Avorn J. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA. 1990;63(4):549–56.CrossRef Soumerai SB, Avorn J. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA. 1990;63(4):549–56.CrossRef
53.
Zurück zum Zitat Federation of State Medical Boards (FSMB) Research and Education Foundation Online Prescriber Education Network (OPEN) Web-based portal: Attorney General Consumer and Prescriber Education Grant Program modules available at http://www.fsmb.org/re/open/modules.html. Accessed April 7, 2009. Federation of State Medical Boards (FSMB) Research and Education Foundation Online Prescriber Education Network (OPEN) Web-based portal: Attorney General Consumer and Prescriber Education Grant Program modules available at http://​www.​fsmb.​org/​re/​open/​modules.​html. Accessed April 7, 2009.
55.
Zurück zum Zitat Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health. 2008;98(2):284–9.PubMedCrossRef Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health. 2008;98(2):284–9.PubMedCrossRef
56.
Zurück zum Zitat Spiller LD, Wymer WW Jr. Physicians’ perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians. Hlth Mark Quart. 2001;19(1):91–106.CrossRef Spiller LD, Wymer WW Jr. Physicians’ perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians. Hlth Mark Quart. 2001;19(1):91–106.CrossRef
57.
58.
Zurück zum Zitat Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4):e1500621–5.CrossRef Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4):e1500621–5.CrossRef
59.
Zurück zum Zitat Eckardt VF. Complimentary journeys to the World Congress of Gastroenterology – an inquiry of potential sponsors and beneficiaries. Zeitschr Gastro. 2000;38(1):7–11.CrossRef Eckardt VF. Complimentary journeys to the World Congress of Gastroenterology – an inquiry of potential sponsors and beneficiaries. Zeitschr Gastro. 2000;38(1):7–11.CrossRef
60.
Zurück zum Zitat Krueger R, Casey M. Focus Groups 3rd ed. Thousand Oaks, CA: Sage Publications; 2000. Krueger R, Casey M. Focus Groups 3rd ed. Thousand Oaks, CA: Sage Publications; 2000.
61.
Zurück zum Zitat Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39–46.PubMedCrossRef Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39–46.PubMedCrossRef
Metadaten
Titel
Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
verfasst von
Melissa A. Fischer, MD, MEd
Mary Ellen Keough, MPH
Joann L. Baril, BS
Laura Saccoccio, BS
Kathleen M. Mazor, EdD
Elissa Ladd, PhD, RN, FNP
Ann Von Worley, RN, BS, CCRP
Jerry H. Gurwitz, MD
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 7/2009
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-0989-6

Weitere Artikel der Ausgabe 7/2009

Journal of General Internal Medicine 7/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.